Physician profile
Michael D Straiko
NPI 1013127075
$15,008.44
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $1,049 · 2021: $169 · 2022: $189 · 2023: $1,062 · 2024: $80.24 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,788 · Travel and Lodging: $1,460 · Food and Beverage: $935 · Honoraria: $600 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,787.50 |
| Travel and Lodging | $1,459.96 |
| Food and Beverage | $935.19 |
| Honoraria | $600.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $11,516.81 | 2021-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Kxl System (Not Refurbished) |
| W. L. Gore & Associates, INC. | $2,350.00 | 2019-2023 | Product In Development |
| Kowa Pharmaceuticals America, INC. | $600.00 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $244.34 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Biotissue Holdings INC. | $103.50 | 2020-2021 | |
| Oyster Point Pharma, INC. | $93.84 | 2022 | |
| Rxsight INC | $57.53 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $42.42 | 2023 | Miebo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Straiko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.